| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/02/1997 | EP0674511B1 Antipyretic and analgesic compositions containing optically pure r-ketorolac |
| 04/02/1997 | CN1034415C Method for prepn. of novel ascorbic acid derivatives |
| 04/01/1997 | US5616688 Macrophage-derived inflammatory mediator (MIP-1α and MIP-1β) |
| 04/01/1997 | US5616684 Cyclic hexapeptide containing aspartic acid and derivatives, 2-thienylglycine, leucine, and tryptophan; endothelin receptor antagonist |
| 04/01/1997 | US5616601 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation |
| 04/01/1997 | US5616596 Substituted arylalkynyl-and heteroarylalkynl-N-hydroxyurea inhibitors of leukotriene biosynthesis |
| 04/01/1997 | US5616573 Glucocorticoids |
| 04/01/1997 | US5616556 Method of treating rheumatoid arthritis and osteoarthrosis using tetrahydro WS9326A |
| 03/27/1997 | WO1997011096A1 Anti-inflammatory agent |
| 03/27/1997 | WO1997011091A1 Novel peptide compounds and medicinal compositions thereof |
| 03/27/1997 | WO1997011090A1 Inhibition of tumor growth |
| 03/27/1997 | WO1997011079A1 Novel imidazole lipoxygenase inhibitors |
| 03/27/1997 | WO1997011071A1 Novel heterocyclic compounds |
| 03/27/1997 | WO1997011069A1 Heterocyclic compounds as bradykinin antagonists |
| 03/27/1997 | WO1997010840A1 Anti-inflammatory antisense drug |
| 03/27/1997 | WO1997010838A1 Use of one or more peptides in a cosmetic composition or for the preparation of a medicament |
| 03/27/1997 | WO1997010834A1 Bioactive factors of aloe vera plants |
| 03/27/1997 | WO1997010828A1 Therapy for tissue membrane insufficiency |
| 03/27/1997 | WO1997010818A1 Method and composition for treating mammalian diseases caused by inflammatory response |
| 03/27/1997 | WO1996039153A3 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis |
| 03/27/1997 | WO1996029974A3 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 03/27/1997 | CA2231835A1 Novel heterocyclic compounds |
| 03/26/1997 | EP0764645A1 Novel 3,4-diaryl furans and analogs thereof having use as anti-inflammatory agents |
| 03/26/1997 | EP0764644A1 Use of medicaments containing 3,4-diaryl furans and analogs thereof for treating a gastrointestinal condition |
| 03/26/1997 | EP0764637A2 2-Cyano-3-mercaptocrotonamides |
| 03/26/1997 | EP0764444A1 Use of at least one peptide in a cosmetic composition or for the preparation of a medicine |
| 03/26/1997 | EP0764171A1 Ligands for induction of antigen specific apoptosis in t cells |
| 03/26/1997 | EP0764167A1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme |
| 03/26/1997 | EP0764166A1 Corticotropin releasing factor antagonists |
| 03/26/1997 | EP0764163A1 Tachykinin (nk 1) receptor antagonists |
| 03/26/1997 | EP0764153A1 Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity |
| 03/26/1997 | EP0764018A1 Non-steroidal anti-inflammatory ophthalmic suspensions |
| 03/26/1997 | EP0649405B1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs |
| 03/26/1997 | EP0539493B1 Targeted drug delivery via phosphonate derivatives |
| 03/26/1997 | CN1146207A Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/26/1997 | CN1146156A Means for treating auto-immune diseases and method of treatment |
| 03/26/1997 | CN1145789A Non-toxic sedative anticancer Chinese medicine capsule |
| 03/26/1997 | CN1145781A Kappa-opiate agonists for inflammatory bowel disorders |
| 03/26/1997 | CN1145779A Medicine matrix and its use |
| 03/26/1997 | CN1034333C Prepn. of imidazopyrazole derivatives as analgesics and anti-inflammatory agents |
| 03/25/1997 | US5614625 Collagenase inhibitors |
| 03/25/1997 | US5614615 Sialyl Lewis X mimetics incorporating fucopeptides |
| 03/25/1997 | US5614555 Amidinophenol derivatives |
| 03/25/1997 | US5614541 Pharmacologically active catechol derivatives |
| 03/25/1997 | US5614540 Compounds useful for treating allergic and inflammatory diseases |
| 03/25/1997 | US5614531 Adhesion receptor antagonists |
| 03/25/1997 | US5614514 Steroid esters |
| 03/25/1997 | US5614488 Cytoxic fragment of a peptide toxin |
| 03/25/1997 | US5614198 Bowman-Birk Inhibitor compositions for treatment of inflammatory disease |
| 03/25/1997 | US5614171 Hydrophilic pharmaceutical composition containing ketoprofen lysine salt for topical use |
| 03/20/1997 | WO1997010236A1 Esters of non-steroidal anti-inflammatory carboxylic acids |
| 03/20/1997 | WO1997010230A1 Diarylalkenylamine derivatives |
| 03/20/1997 | WO1997010227A1 Benzothiazolone derivatives |
| 03/20/1997 | WO1997010219A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases |
| 03/20/1997 | WO1997010205A1 A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same |
| 03/20/1997 | WO1997009992A1 Lipid extract having anti-inflammatory activity |
| 03/20/1997 | WO1997009977A1 Specific cyclooxygenase 2 inhibitor and anti-inflammatory agent |
| 03/20/1997 | WO1997000952A3 A human edg-2 receptor homolog |
| 03/20/1997 | CA2232161A1 Diarylalkenylamine derivatives |
| 03/20/1997 | CA2231996A1 A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same |
| 03/20/1997 | CA2231164A1 Esters of non-steroidal anti-inflammatory carboxylic acids |
| 03/20/1997 | CA2231003A1 Benzothiazolone derivatives |
| 03/20/1997 | CA2230970A1 Specific cyclooxygenase 2 inhibitor and anti-inflammatory agent |
| 03/20/1997 | CA2185850A1 2-cyano-3-mercaptocrotonamides |
| 03/19/1997 | EP0763597A2 Use of cytohesin-PH peptides to influence the adhesion capability of integrins |
| 03/19/1997 | EP0763543A2 A method for preparing an inflammatory cytokine (MIP-2) and diagnostic and therapeutic applications for the cytokine or its antibody |
| 03/19/1997 | EP0763534A1 Arylalkyl-diazinone derivatives as phosphodiesterase IV inhibitors |
| 03/19/1997 | EP0763362A2 A pharmaceutical base in ointment form and its use |
| 03/19/1997 | EP0763055A1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
| 03/19/1997 | EP0763039A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 03/19/1997 | EP0763037A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763036A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763016A1 Compositions and methods for treating mast-cell mediated conditions |
| 03/19/1997 | EP0763012A1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors |
| 03/19/1997 | EP0762887A1 Acylated enol derivatives as prodrugs of elastase inhibitors |
| 03/19/1997 | EP0762881A1 Method and reagents for the treatment of rheumatoid arthritis |
| 03/19/1997 | EP0762876A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof |
| 03/19/1997 | EP0751948A4 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 03/19/1997 | EP0675881B1 Use of benzotriazines as PLA2-Inhibitors and new benzotriazines |
| 03/19/1997 | EP0667770B1 Inhibition of tnf production |
| 03/19/1997 | EP0647136B1 Use of condensed bis-(3,4-dihydro-pyridinyl)methane for treating crohn's disease, colitis ulcerosa, chronic inflamatory processes and as an antiproliferative |
| 03/19/1997 | EP0634998B1 Hydroxamic acid based collagenase and cytokine inhibitors |
| 03/19/1997 | EP0624087B1 Spray-chilled nabumetone |
| 03/19/1997 | EP0607373B1 Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors |
| 03/19/1997 | CN1145637A Alpha-1-antichymotrypsin analogues having elastase inhibitory activity |
| 03/19/1997 | CN1145636A Vascular endothelial growth factor 2 |
| 03/19/1997 | CN1145619A Substituted pyridine leukotriene B4 antagonists |
| 03/18/1997 | US5612369 Treatment of arterial and venous thrombotic occlusive disorders, inflammation, cancer, and neurodegenerative diseases |
| 03/18/1997 | US5612367 Method of enhancing bioavailability of pharmaceutical agents |
| 03/18/1997 | US5612359 Substituted biphenyl isoxazole sulfonamides |
| 03/18/1997 | US5612356 Retinoid antagonists |
| 03/18/1997 | US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms |
| 03/18/1997 | US5612337 Analgesic compounds for prodrugs |
| 03/18/1997 | US5612335 Anticoagulants; combating/preventing diseases where cell aggregates occur or cell-matrix interactions play a part |
| 03/18/1997 | US5612330 Herpes virus |
| 03/18/1997 | US5612325 Antiinflammatory and immunomodulating effects |
| 03/18/1997 | US5612194 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/15/1997 | CA2185517A1 Use of cytohesin-ph peptides for influencing the ability of integrins to adhere |
| 03/13/1997 | WO1997009351A1 Recombinant anti-cd4 antibodies for human therapy |
| 03/13/1997 | WO1997009335A1 Substituted phosphinic compounds and their use as pharmaceuticals |